Thrombolysis in acute ischemic stroke in centers lacking a stroke unit: Referral to reference center or on-site treatment?;Trombolisis en el ictus isquémico agudo en centros sin unidad de ictus: ¿derivación a centro de referencia o tratamiento in situ?

Medicina Intensiva

Volumn 36, Issue 5, 2012, Pages 324-328

  Latour Perez J ^a   Galdos Anuncibay, P ^b  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Decision support techniques; Stroke; Thrombolytic therapy

Indexed keywords

ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; EMERGENCY TREATMENT; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL DECISION MAKING; META ANALYSIS; MONTE CARLO METHOD; ON SITE TREATMENT; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; STROKE UNIT; THERAPY DELAY;

BRAIN DAMAGE, CHRONIC; BRAIN ISCHEMIA; COHORT STUDIES; COMPUTER SIMULATION; DECISION TREES; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HOSPITAL UNITS; HUMANS; META-ANALYSIS AS TOPIC; MODELS, THEORETICAL; PATIENT TRANSFER; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFERRAL AND CONSULTATION; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84861685625     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2011.12.007     Document Type: Article

References (21)

1. Wardlaw J.M., Murray V., Berge E., Del Zoppo G.J. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2009, CD000213.
2. Lees K.R., Bluhmki E., Von Kummer R., Brott T.G., Toni D., Grotta J.C., et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010, 375:1695-1703.
3. Ministerio de Sanidad y Política Social, editor Estrategia en Ictus del Sistema Nacional de Salud 2008, Ministerio de Sanidad y Política Social, Madrid.
4. Díez Tejedor E., Egido Herrero J.A., Gil Núñez A., Matías Guiu Guía J., Alonso de Leciñana M., Sánchez Sánchez C., et al. Atención a los pacientes con ictus en la Comunidad de Madrid 2009, Comunidad de Madrid, Madrid.
5. Masjuan J., Alvarez-Sabin J., Arenillas J., Calleja S., Castillo J., Davalos A., et al. Plan de asistencia sanitaria al ICTUS II. Neurologia 2010, 2010.
6. Direcció General d'Asistència Sanitària, editor., 2000. Plan de atención al ictus en la Comunidad Valenciana 2011-2015. Valencia: Consellería de Sanitat; 2011.
7. Zhang J., Yu K.F. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998, 280:1690-1691.
8. Sox H., Blatt M., Higgins M., Marton K. Medical Decision Making 2007, American College of Physicians, Philadelphia.
9. Doubilet P., Begg C.B., Weinstein M.C., Braun P., McNeil B.J. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 1985, 5:157-177.
10. Hunink M., Glasziou P., Siegel J., Weeks J., Pliskin J., Elstein A., et al. Decision making in health and medicine 2001, Cambridge University Press.
11. Wahlgren N., Ahmed N., Davalos A., Ford G.A., Grond M., Hacke W., et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007, 369:275-282.
12. Choi H. Views & Reviews: Personal View: Thrombolysis in acute ischaemic stroke: example of a health divide?. BMJ 2010, 340:c45.
13. Perez de la Ossa N., Millan M., Arenillas J.F., Sanchez-Ojanguren J., Palomeras E., Dorado L., et al. Influence of direct admission to Comprehensive Stroke Centers on the outcome of acute stroke patients treated with intravenous thrombolysis. J Neurol 2009, 256:1270-1276.
14. Gladstone D.J., Rodan L.H., Sahlas D.J., Lee L., Murray B.J., Ween J.E., et al. A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke 2009, 40:3841-3844.
15. Varela A., De Rojas P., Vegas R., Vazquez A., Cabello B., Zaheri M. Trombolisis en el ictus isquemico agudo en hospitales basicos. A propósito de cuatro casos. Med Intensiva 2010, 34:428-430.
16. Schwamm L.H., Holloway R.G., Amarenco P., Audebert H.J., Bakas T., Chumbler N.R., et al. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke 2009, 40:2616-2634.
17. Pedragosa A., álvarez-Sabín J., Molina C.A., Brugués J., Ribó M. Trombólisis endovenosa en un hospital comarcal mediante el sistema teleictus. Rev Neurol 2011, 53:139-145.
18. Martin-Schild S., Morales M., Khaja A., Barreto A., Hallevi H., Abraham A., et al. Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe?. J Emerg Med 2009.
19. Chernyshev O., Martin-Schild S., Albright K., Barreto A., Misra V., Acosta I., et al. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology 2010, 74:1340.
20. Gillum L.A., Johnston S.C. Influence of physician specialty on outcomes after acute ischemic stroke. J Hosp Med 2008, 3:184-192.
21. Fonarow G.C., Smith E.E., Saver J.L., Reeves M.J., Bhatt D.L., Grau-Sepulveda M.V., et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60minutes. Circulation 2011, 123:750-758.